Table 3
Characteristics for patients receiving a digital rectal examination, stratified by quality metric timing
| Patient characteristics | ≤6 months before Tx n=3742 | 6+ months before Tx n=1479 | P value |
Age at diagnosis (years),   | 65.81±8.83 | 67.54±9.41 | |
| Insurance payor type, n (%) | |||
| Private | 1219 (77.3) | 357 (22.7) | <0.001 |
| Medicare/Medical | 2269 (69.5) | 995 (30.5) | |
| Ethnicity, n (%) | |||
| Non-Hispanic | 3431 (71.7) | 1353 (28.3) | 0.767 |
| Hispanic | 281 (72.4) | 107 (27.6) | |
| Race, n (%) | |||
| Asian | 423 (73.7) | 151 (26.3) | 0.523 |
| White | 2809 (71.4) | 1124 (28.6) | |
| Other* | 222 (72.1) | 86 (27.9) | |
| First line of treatment, n (%) | |||
| Active surveillance | 248 (44.8) | 306 (55.2) | <0.001 |
| Chemotherapy | 137 (64.9) | 74 (35.1) | |
| Hormone therapy | 768 (62.8) | 455 (37.2) | |
| Radiation therapy | 612 (73.6) | 220 (26.4) | |
| Surgery | 1977 (82.3) | 424 (17.7) | |
| Stage, n (%) | |||
| 1 | 332 (62.5) | 199 (37.5) | <0.001 |
| 2 | 2102 (74.5) | 720 (25.5) | |
| 3 | 607 (84.7) | 110 (15.3) | |
| 4 | 286 (67.6) | 137 (32.4) | |
Tx, treatment.